AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 37 filers reported holding AIM IMMUNOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,864 | -32.1% | 37,063 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $24,832 | +55.8% | 37,063 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $15,937 | +37.9% | 37,063 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,560 | -49.7% | 37,063 | -7.5% | 0.00% | -33.3% |
| Q3 2022 | $23,000 | -25.8% | 40,063 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $31,000 | -26.2% | 40,063 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $42,000 | +20.0% | 40,063 | +3.9% | 0.01% | +25.0% |
| Q4 2021 | $35,000 | -60.2% | 38,563 | -11.5% | 0.00% | -63.6% |
| Q3 2021 | $88,000 | -6.4% | 43,563 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $94,000 | -5.1% | 43,563 | 0.0% | 0.01% | -15.4% |
| Q1 2021 | $99,000 | +13.8% | 43,563 | -10.9% | 0.01% | +8.3% |
| Q4 2020 | $87,000 | -20.2% | 48,873 | -3.3% | 0.01% | -29.4% |
| Q3 2020 | $109,000 | -5.2% | 50,515 | +8.5% | 0.02% | -15.0% |
| Q2 2020 | $115,000 | – | 46,563 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |